PL1755583T3 - Zastosowanie neboglaminy do leczenia schizofrenii - Google Patents
Zastosowanie neboglaminy do leczenia schizofreniiInfo
- Publication number
- PL1755583T3 PL1755583T3 PL05747915T PL05747915T PL1755583T3 PL 1755583 T3 PL1755583 T3 PL 1755583T3 PL 05747915 T PL05747915 T PL 05747915T PL 05747915 T PL05747915 T PL 05747915T PL 1755583 T3 PL1755583 T3 PL 1755583T3
- Authority
- PL
- Poland
- Prior art keywords
- neboglamine
- schizophrenia
- treatment
- dimethylcyclohexyl
- racemate
- Prior art date
Links
- VCRGLZYPNNAVRP-JTQLQIEISA-N (4s)-4-amino-5-[(4,4-dimethylcyclohexyl)amino]-5-oxopentanoic acid Chemical compound CC1(C)CCC(NC(=O)[C@@H](N)CCC(O)=O)CC1 VCRGLZYPNNAVRP-JTQLQIEISA-N 0.000 title abstract 4
- 229950007573 neboglamine Drugs 0.000 title abstract 2
- 201000000980 schizophrenia Diseases 0.000 title abstract 2
- NTCVVGBUOCVHTI-AXDSSHIGSA-N (4s)-2-amino-4-[(4,4-dimethylcyclohexyl)amino]pentanedioic acid Chemical compound CC1(C)CCC(N[C@@H](CC(N)C(O)=O)C(O)=O)CC1 NTCVVGBUOCVHTI-AXDSSHIGSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000343A ITTO20040343A1 (it) | 2004-05-24 | 2004-05-24 | Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo |
| PCT/EP2005/052340 WO2005115373A1 (en) | 2004-05-24 | 2005-05-23 | Use of neboglamine (cr 2249) as an antipsychotic and neuroprotective |
| EP05747915A EP1755583B1 (en) | 2004-05-24 | 2005-05-23 | Use of neboglamine for the treatment of schizophrenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1755583T3 true PL1755583T3 (pl) | 2010-09-30 |
Family
ID=34968609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05747915T PL1755583T3 (pl) | 2004-05-24 | 2005-05-23 | Zastosowanie neboglaminy do leczenia schizofrenii |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7737180B2 (pl) |
| EP (1) | EP1755583B1 (pl) |
| JP (1) | JP4898666B2 (pl) |
| AT (1) | ATE464042T1 (pl) |
| AU (1) | AU2005247114B2 (pl) |
| CA (1) | CA2567397C (pl) |
| DE (1) | DE602005020618D1 (pl) |
| DK (1) | DK1755583T3 (pl) |
| ES (1) | ES2340399T3 (pl) |
| IT (1) | ITTO20040343A1 (pl) |
| PL (1) | PL1755583T3 (pl) |
| PT (1) | PT1755583E (pl) |
| WO (1) | WO2005115373A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITTO20050691A1 (it) * | 2005-10-04 | 2007-04-05 | Rottapharm Spa | Uso di neboglamine nella terapia delle tossicodipendenze |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1931927A1 (de) * | 1968-07-06 | 1970-01-15 | Yamanouchi Pharma Co Ltd | Neue Cyclohexylaminderivate |
| IT1264765B1 (it) | 1993-03-10 | 1996-10-04 | Rotta Research Lab | Derivati dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso come farmaci potenzianti la |
| TW200304374A (en) | 2001-11-30 | 2003-10-01 | Smithkline Beecham Plc | Novel compounds |
-
2004
- 2004-05-24 IT IT000343A patent/ITTO20040343A1/it unknown
-
2005
- 2005-05-23 WO PCT/EP2005/052340 patent/WO2005115373A1/en not_active Ceased
- 2005-05-23 CA CA2567397A patent/CA2567397C/en not_active Expired - Fee Related
- 2005-05-23 AU AU2005247114A patent/AU2005247114B2/en not_active Ceased
- 2005-05-23 DK DK05747915.6T patent/DK1755583T3/da active
- 2005-05-23 PL PL05747915T patent/PL1755583T3/pl unknown
- 2005-05-23 AT AT05747915T patent/ATE464042T1/de active
- 2005-05-23 ES ES05747915T patent/ES2340399T3/es not_active Expired - Lifetime
- 2005-05-23 DE DE602005020618T patent/DE602005020618D1/de not_active Expired - Lifetime
- 2005-05-23 JP JP2007513918A patent/JP4898666B2/ja not_active Expired - Fee Related
- 2005-05-23 EP EP05747915A patent/EP1755583B1/en not_active Expired - Lifetime
- 2005-05-23 US US11/569,545 patent/US7737180B2/en not_active Expired - Fee Related
- 2005-05-23 PT PT05747915T patent/PT1755583E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE464042T1 (de) | 2010-04-15 |
| CA2567397A1 (en) | 2005-12-08 |
| ITTO20040343A1 (it) | 2004-08-24 |
| AU2005247114A1 (en) | 2005-12-08 |
| CA2567397C (en) | 2013-03-12 |
| PT1755583E (pt) | 2010-05-07 |
| DK1755583T3 (da) | 2010-07-19 |
| EP1755583A1 (en) | 2007-02-28 |
| US20070249715A1 (en) | 2007-10-25 |
| JP2008500309A (ja) | 2008-01-10 |
| EP1755583B1 (en) | 2010-04-14 |
| US7737180B2 (en) | 2010-06-15 |
| JP4898666B2 (ja) | 2012-03-21 |
| DE602005020618D1 (de) | 2010-05-27 |
| AU2005247114B2 (en) | 2010-06-03 |
| WO2005115373A1 (en) | 2005-12-08 |
| ES2340399T3 (es) | 2010-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL213649A0 (en) | Prodrugs of gabapentin compounds, compositions and their use in the manufacture of a medicament | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| BG106158A (en) | New use of compounds as antibacterial agents | |
| UA83233C2 (ru) | Замещенный 2-аминотетралин для лечения депрессии | |
| EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| UA83691C2 (ru) | Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона | |
| SI1694318T1 (sl) | (S)-2-N-propilamino-5-hidroksitetralin kot terapevtsko sredstvo z agonističnim učinkom na D3 | |
| NO20050060L (no) | Medikament for behandling av overaktiv blaere | |
| DK1641454T3 (da) | Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere | |
| WO2008032222A3 (en) | Treatment of vertigo with acetyl-l-leucine | |
| WO2002092072A3 (en) | Drugs for the treatment of the alzheimer disease | |
| TW200531688A (en) | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents | |
| WO2007126898A8 (en) | Use of ladostigil for the treatment of schizophrenia | |
| EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
| WO2002060533A3 (de) | Betamimetika enthaltende arzneimittelkompositionen mit geringere n nebenwirkungen | |
| WO2006130726A3 (en) | Use of ladostigil for the treatment of multiple sclerosis | |
| AU2002365288A1 (en) | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases | |
| TW200640890A (en) | Crystalline base of a pharmaceutical compound | |
| DK1755583T3 (da) | Anvendelse af neboglamin til behandling af skizofreni | |
| WO2008120617A1 (ja) | クローン病に伴う腸管狭窄の進展抑制用医薬組成物 | |
| MXPA05010135A (es) | Nuevos derivados de oxazol, procedimiento para su fabricacion y uso como agentes farmaceuticos. | |
| MX2009004682A (es) | Uso de dmae para el tratamiento de deficit cognitivo ligero. | |
| TW200720239A (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
| HUP0301873A2 (hu) | Gyógyszerkészítmény légzési nehézségek kezelésére | |
| TW200602329A (en) | Novel diazine derivatives, their manufacture and use as pharmaceutical agents |